Characterization of AmiBA2446, a novel bacteriolytic enzyme active against bacillus species

Applied and Environmental Microbiology

Volumn 79, Issue 19, 2013, Pages 5899-5906

  Mehta, Krunal K ^a,b   Paskaleva, Elena E ^a,b   Azizi Ghannad, Saba ^c   Ley, Daniel J ^d   Page, Martin A ^d   Dordick, Jonathan S ^a,b,c   Kanea, Ravi S ^a,b  

^a Rensselaer Polytechnic Institute   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^d U S ARMY ENGINEER RESEARCH AND DEVELOPMENT CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; BACILLUS ANTHRACIS; BACTERICIDAL ACTIVITY; BACTERIOLYTIC ENZYME; ENZYMATIC DIGESTIONS; ENZYME CONCENTRATIONS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; PHYLOGENETIC ANALYSIS;

AMINO ACIDS; BACILLUS CEREUS; BACTERICIDES; BACTERIOLOGY; GENES; ORGANIC POLYMERS;

ENZYMES;

AMINO ACID; ENZYME ACTIVITY; GENOME; GROWTH RATE; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; PEPTIDE; PHYLOGENETICS; SPORE;

ANTIINFECTIVE AGENT; N ACETYLMURAMOYLALANINE AMIDASE; PEPTIDOGLYCAN;

ARTICLE; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIOLYSIS; CLUSTER ANALYSIS; DRUG EFFECT; ENZYMOLOGY; GENETICS; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; MICROBIAL VIABILITY; PHYLOGENY; SEQUENCE HOMOLOGY;

ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIOLYSIS; CHROMATOGRAPHY, LIQUID; CLUSTER ANALYSIS; HYDROLYSIS; MASS SPECTROMETRY; MICROBIAL VIABILITY; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDOGLYCAN; PHYLOGENY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84884197591     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02235-13     Document Type: Article

References (53)

1. Menzies RE, Cornere BM, MacCulloch D. 1989. Adaptation of methicillin-resistant Staphylococcus aureus during antibiotic therapy. J. Antimicrob. Chemother. 23:923-927.
2. Fischetti VA. 2008. Bacteriophage lysins as effective antibacterials. Curr. Opin. Microbiol. 11:393-400.
3. Kropinski AM. 2006. Phage therapy-everything old is new again. Can. J. Infect. Dis. Med. Microbiol. 17:297-306.
4. Borysowski J, Weber-Dabrowska B, Gorski A. 2005. The potential use of bacteriophages in view of the current antibiotic therapy crisis. Pol. Arch. Med. Wewn. 113:73-78.
5. Bourguet FA, Souza BE, Hinz AK, Coleman MA, Jackson PJ. 2012. Characterization of a novel lytic protein encoded by the Bacillus cereus E33L gene ampD as a Bacillus anthracis antimicrobial protein. Appl. Environ. Microbiol. 78:3025-3027.
6. Delbruck M. 1940. The growth of bacteriophage and lysis of the host. J. Gen. Physiol. 23:643-660.
7. Courchesne NM, Parisien A, Lan CQ. 2009. Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Pat. Biotechnol. 3:37-45.
8. Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM. 2012. Endolysins as antimicrobials. Adv. Virus Res. 83:299-365.
9. Deutsch SM, Guezenec S, Piot M, Foster S, Lortal S. 2004. Mur-LH, the broad-spectrum endolysin of Lactobacillus helveticus temperate bacteriophage phi-0303. Appl. Environ. Microbiol. 70:96-103.
10. Lopez R, Garcia E, Garcia P, Garcia JL. 1997. The pneumococcal cell wall degrading enzymes: a modular design to create new lysins? Microb. Drug Resist. 3:199-211.
11. Shockman GD, Daneo-Moore L, Kariyama R, Massidda O. 1996. Bacterial walls, peptidoglycan hydrolases, autolysins, and autolysis. Microb. Drug Resist. 2:95-98.
12. Loessner MJ. 2005. Bacteriophage endolysins-current state of research and applications. Curr. Opin. Microbiol. 8:480-487.
13. Porter CJ, Schuch R, Pelzek AJ, Buckle AM, McGowan S, Wilce MC, Rossjohn J, Russell R, Nelson D, Fischetti VA, Whisstock JC. 2007. The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis. J. Mol. Biol. 366:540-550.
14. Pritchard DG, Dong S, Kirk MC, Cartee RT, Baker JR. 2007. LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Appl. Environ. Microbiol. 73:7150-7154.
15. Blackburn NT, Clarke AJ. 2001. Identification of four families of peptidoglycan lytic transglycosylases. J. Mol. Evol. 52:78-84.
16. Schuch R, Nelson D, Fischetti VA. 2002. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418:884-889.
17. Korndorfer IP, Kanitz A, Danzer J, Zimmer M, Loessner MJ, Skerra A. 2008. Structural analysis of the L-alanoyl-D-glutamate endopeptidase domain of Listeria bacteriophage endolysin Ply500 reveals a new member of the LAS peptidase family. Acta Crystallogr. D Biol. Crystallogr. 64:644-650.
18. Baker JR, Liu C, Dong S, Pritchard DG. 2006. Endopeptidase and glycosidase activities of the bacteriophage B30 lysin. Appl. Environ. Microbiol. 72:6825-6828.
19. Mayer, M. J., Garefalaki V, Spoerl R, Narbad A, and Meijers R. 2011. Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range. J. Bacteriol. 193:5477-5486.
20. Schmitz JE, Schuch R, Fischetti VA. 2010. Identifying active phage lysins through functional viral metagenomics. Appl. Environ. Microbiol. 76: 7181-7187.
21. Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. 2011. Anthrax infection. Am. J. Respir. Crit. Care Med. 184:1333-1341.
22. Keim P, Smith KL, Keys C, Takahashi H, Kurata T, Kaufmann A. 2001. Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan. J. Clin. Microbiol. 39:4566-4567.
23. Mayer TA, Bersoff-Matcha S, Murphy C, Earls J, Harper S, Pauze D, Nguyen M, Rosenthal J, Cerva D, Jr, Druckenbrod G, Hanfling D, Fatteh N, Napoli A, Nayyar A, Berman EL. 2001. Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA 286:2549-2553.
24. Weiss MM, Weiss PD, Weiss JB. 2007. Anthrax vaccine and public health policy. Am. J. Public Health 97:1945-1951.
25. Driks A. 2003. The dynamic spore. Proc. Natl. Acad. Sci. U. S. A. 100: 3007-3009.
26. Loessner MJ, Maier SK, Daubek-Puza H, Wendlinger G, Scherer S. 1997. Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. J. Bacteriol. 179:2845-2851.
27. Low LY, Yang C, Perego M, Osterman A, Liddington RC. 2005. Structure and lytic activity of a Bacillus anthracis prophage endolysin. J. Biol. Chem. 280:35433-35439.
28. Yoong P, Schuch R, Nelson D, Fischetti VA. 2006. PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. J. Bacteriol. 188:2711-2714.
29. Stewart BT, Halvorson HO. 1953. Studies on the spores of aerobic bacteria. I. The occurrence of alanine racemase. J. Bacteriol. 65:160-166.
30. Shah IM, Laaberki MH, Popham DL, Dworkin J. 2008. A eukaryotic-like Ser/Thr kinase signals bacteria to exit dormancy in response to peptidoglycan fragments. Cell 135:486-496.
31. Korndorfer IP, Danzer J, Schmelcher M, Zimmer M, Skerra A, Loessner MJ. 2006. The crystal structure of the bacteriophage PSA endolysin reveals a unique fold responsible for specific recognition of Listeria cell walls. J. Mol. Biol. 364:678-689.
32. Rajalakshmi N, Sundaram PV. 1995. Stability of native and covalently modified papain. Protein Eng. 8:1039-1047.
33. Gouda MD, Singh SA, Rao AG, Thakur MS, Karanth NG. 2003. Thermal inactivation of glucose oxidase. Mechanism and stabilization using additives. J. Biol. Chem. 278:24324-24333.
34. Dougherty TJ. 1985. Analysis of Neisseria gonorrhoeae peptidoglycan by reverse-phase, high-pressure liquid chromatography. J. Bacteriol. 163:69-74.
35. Loessner MJ, Kramer K, Ebel F, Scherer S. 2002. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol. Microbiol. 44:335-349.
36. Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, Holtzapple EK, Okstad OA, Helgason E, Rilstone J, Wu M, Kolonay JF, Beanan MJ, Dodson RJ, Brinkac LM, Gwinn M, DeBoy RT, Madpu R, Daugherty SC, Durkin AS, Haft DH, Nelson WC, Peterson JD, Pop M, Khouri HM, Radune D, Benton JL, Mahamoud Y, Jiang L, Hance IR, Weidman JF, Berry KJ, Plaut RD, Wolf AM, Watkins KL, Nierman WC, Hazen A, Cline R, Redmond C, Thwaite JE, White O, Salzberg SL, Thomason B, Friedlander AM, Koehler TM, Hanna PC, Kolsto AB, Fraser CM. 2003. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423:81-86.
37. Marchler-Bauer A, Bryant SH. 2004. CD-Search: protein domain annotations on the fly. Nucleic Acids Res. 32:W327-W331.
38. Marchler-Bauer A, Zheng C, Chitsaz F, Derbyshire MK, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Lanczycki CJ, Lu F, Lu S, Marchler GH, Song JS, Thanki N, Yamashita RA, Zhang D, Bryant SH. 2013. CDD: conserved domains and protein three-dimensional structure. Nucleic Acids Res. 41:D348-D352.
39. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Lu F, Marchler GH, Mullokandov M, Omelchenko MV, Robertson CL, Song JS, Thanki N, Yamashita RA, Zhang D, Zhang N, Zheng C, Bryant SH. 2011. CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res. 39:D225-D229.
40. Sainath Rao S, Mohan KVK, Nguyen N, Abraham B, Abdouleva G, Zhang P, Atreya CD. Peptides panned from a phage-displayed random peptide library are useful for the detection of Bacillus anthracis surrogates B. cereus 4342 and B. anthracis Sterne. Biochem. Biophys. Res. Commun. 395:93-98.
41. Greenberg DL, Busch JD, Keim P, Wagner DM. 2010. Identifying experimental surrogates for Bacillus anthracis spores: a review. Invest. Genet. 1:4.
42. Sundaram PV, Venkatesh R. 1998. Retardation of thermal and urea induced inactivation of alpha-chymotrypsin by modification with carbohydrate polymers. Protein Eng. 11:699-705.
43. Venkatesh R, Sundaram PV. 1998. Modulation of stability properties of bovine trypsin after in vitro structural changes with a variety of chemical modifiers. Protein Eng. 11:691-698.
44. Loeffler JM, Djurkovic S, Fischetti VA. 2003. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect. Immun. 71: 6199-6204.
45. Lee JH, Shin H, Son B, Ryu S. 2012. Complete genome sequence of Bacillus cereus bacteriophage BCP78. J. Virol. 86:637-638.
46. Fan LT, Lee YH. 1983. Kinetic studies of enzymatic hydrolysis of insoluble cellulose: Derivation of a mechanistic kinetic model. Biotechnol. Bioeng. 25:2707-2733.
47. Klyosov AA. 1990. Trends in biochemistry and enzymology of cellulose degradation. Biochemistry 29:10577-10585.
48. Lynd LR, Weimer PJ, van Zyl WH, Pretorius IS. 2002. Microbial cellulose utilization: fundamentals and biotechnology. Microbiol. Mol. Biol. Rev. 66:506-577.
49. Helgason E, Okstad OA, Caugant DA, Johansen HA, Fouet A, Mock M, Hegna I, Kolsto AB. 2000. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis-one species on the basis of genetic evidence. Appl. Environ. Microbiol. 66:2627-2630.
50. LeoffC, Choudhury B, Saile E, Quinn CP, Carlson RW, Kannenberg EL. 2008. Structural elucidation of the nonclassical secondary cell wall polysaccharide from Bacillus cereus ATCC 10987. Comparison with the polysaccharides from Bacillus anthracis and. B. cereus type strain ATCC 14579 reveals both unique and common structural features. J. Biol. Chem. 283:29812-29821.
51. Grover N, Douaisi MP, Borkar IV, Lee L, Dinu CZ, Kane RS, Dordick JS. 2012. Perhydrolase-nanotube paint composites with sporicidal and antiviral activity. Appl. Microbiol. Biotechnol. doi:10.1007/s00253-012-4573-3.
52. Pangule RC, Brooks SJ, Dinu CZ, Bale SS, Salmon SL, Zhu G, Metzger DW, Kane RS, Dordick JS. 2010. Antistaphylococcal nanocomposite films based on enzyme-nanotube conjugates. ACS Nano 4:3993-4000.
53. Grover N, Borkar IV, Dinu CZ, Kane RS, Dordick JS. 2012. Laccase-and chloroperoxidase-nanotube paint composites with bactericidal and sporicidal activity. Enzyme Microb. Technol. 50:271-279.